Schwannomatosis clinical trials

Explore recruiting schwannomatosis clinical trials.

Recruiting schwannomatosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Schwannomatosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(NFPET) ‘89Zr-Bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic neurofibromatosis type 2

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Schwannomatosis trials by city

Schwannomatosis in Toronto Schwannomatosis in Vancouver Schwannomatosis in Montreal Schwannomatosis in Calgary Schwannomatosis in Edmonton Schwannomatosis in Ottawa Schwannomatosis in Winnipeg Schwannomatosis in Quebec City Schwannomatosis in Hamilton Schwannomatosis in Kitchener Schwannomatosis in London Schwannomatosis in Halifax Schwannomatosis in New York Schwannomatosis in Los Angeles Schwannomatosis in Chicago Schwannomatosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease